Results 141 to 150 of about 108,045 (161)

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial

Lancet, The, 2009
Paul M Ridker, Jacques Genest jr, Wolfgang Koenig   +2 more
exaly  

Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials

Lancet, The, 2020
Baris Gencer, Eugene Braunwald, Marc S Sabatine   +2 more
exaly  

Low-Density Lipoprotein (LDL)

2012
openaire   +1 more source

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

Lancet, The, 2012
Colin Baigent
exaly  

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2010
Frederick J Raal, Dirk J Blom, A David Marais   +2 more
exaly  

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

Lancet, The, 2011
Colin Baigent, Martin J Landray, Jonathan R Emberson   +2 more
exaly  

Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12 064 survivors of myocardial infarction: a double-blind randomised trial

Lancet, The, 2010
Jane Armitage, Frcp, Louise Bowman, Karl Wallendszus   +2 more
exaly  

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

Lancet, The, 1992
exaly  

SR-B1 drives endothelial cell LDL transcytosis via DOCK4 to promote atherosclerosis

Nature, 2019
Peter Michaely, Anza Darehshouri, Lin Xu
exaly  

The LDL Receptor in Lipoprotein Turnover

1984
openaire   +1 more source